Bio-Gene Technology Ltd. (AU:BGT) has released an update.
Bio-Gene Technology Ltd. is partnering with Envu to advance Flavocide, a novel bio-insecticide, for mosquito control in professional and public health sectors. The collaboration aims to integrate Bio-Gene’s innovation with Envu’s formulation expertise, showing promising results against insecticide-resistant mosquitoes. Flavocide, a nature-identical compound, is part of a strategic effort to combat global mosquito-borne diseases and insecticide resistance.
For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.